Fractyl (United States)

Recent papers from Fractyl (United States)

1. The immunogenicity database collaborative: a standardized, publicly available database for clinical immunogenicity observations and insightsFrontiers in Immunology · 2026
2. A look at duodenal mucosal resurfacing: Rationale for targeting the duodenum in type 2 diabetesDiabetes Obesity and Metabolism · 2024
3. Insulin sensitivity and beta cell function after duodenal mucosal resurfacing: an open-label, mechanistic, pilot studyGastrointestinal Endoscopy · 2024
4. Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 Study)Diabetes Research and Clinical Practice · 2022
5. A Gut-Centric Model of Metabolic HomeostasisJournal of Diabetes Science and Technology · 2021
6. Chronic peptide-based GIP receptor inhibition exhibits modest glucose metabolic changes in mice when administered either alone or combined with GLP-1 agonismPLoS ONE · 2021
7. Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trialGut · 2021
8. Peptide-based GIP receptor inhibition exhibits modest metabolic changes in mice when administered either alone or combined with GLP-1 agonism2019
9. Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 DiabetesDigestive Diseases · 2018
10. Age and sex in drug development and testing for adultsPharmacological Research · 2017
11. Hydrothermal Duodenal Mucosal ResurfacingGastrointestinal Endoscopy Clinics of North America · 2017
12. Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept StudyDiabetes Care · 2016
13. Bronchopulmonary dysplasia and very low birthweight: Lung function at 11 years of ageJournal of Paediatrics and Child Health · 1996